XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)
$5.5 -1.38 (-20.0581%)
Analysed XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) News Sources
Change of Date for Publication of the Interim Report January-March 2026
10-02-2026
yahoo.com
XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe
11-08-2026
yahoo.com
XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System
28-09-2026
yahoo.com
Nomination Committee of XVIVO Perfusion AB (publ)
30-09-2026
yahoo.com
What is the current price of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The current price of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is $5.5.
XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) since the previous trading day is $-1.38.
XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) since the previous trading day is -20.0581%.
What is the most recent average sentiment score for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The most recent average sentiment score for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is 45 out of 100.
What is the most recent average sentiment for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The most recent sentiment for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is .
SEC-8K** Filing Available For XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.